100% of patients in the REVEAL-1 Cohort maintained at least 5% of GLP-1-induced weight loss through one year: This 5% threshold is the responder definition used as the second co-primary endpoint in the REMAIN-1 Pivotal Cohort, which evaluates a responder rate among the Revita treated participants at one year to assess the durability of the Revita procedure for weight maintenance after GLP-1 discontinuation
Dada la enorme problemtica que supone el exceso de kilos, algunos pases han empezado a financiar Wegovy y Saxenda dentro de su sistema pblico de salud
What qualifies as an HSA- or FSA-eligible expense
Wang W-Y, Liu X, Gao X-Q, Li X, Fang Z-Z
This approach, known as start low and go slow, is often used during the dose-escalation phase of Semaglutide treatment
doi:10.1107/S2059798324007794